How BioCryst aims to use its $80M public offering
September 14, 2017 at 14:55 PM EDT
This week, Durham-based BioCryst Pharmaceuticals (Nasdaq: BCRX) announced an $80 million public offering of the company’s common stock.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|